Literature DB >> 32350002

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.

Zhikang Ye1, Bram Rochwerg1, Ying Wang1, Neill K Adhikari1, Srinivas Murthy1, François Lamontagne1, Robert A Fowler1, Haibo Qiu1, Li Wei1, Ling Sang1, Mark Loeb1, Ning Shen1, Minhua Huang1, Zhaonan Jiang1, Yaseen M Arabi1, Luis Enrique Colunga-Lozano1, Li Jiang1, Younsuck Koh1, Dong Liu1, Fang Liu1, Jason Phua1, Aizong Shen1, Tianyi Huo1, Bin Du2, Suodi Zhai1, Gordon H Guyatt1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32350002      PMCID: PMC7241888          DOI: 10.1503/cmaj.200648

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  28 in total

1.  GRADE guidelines 6. Rating the quality of evidence--imprecision.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; David Rind; P J Devereaux; Victor M Montori; Bo Freyschuss; Gunn Vist; Roman Jaeschke; John W Williams; Mohammad Hassan Murad; David Sinclair; Yngve Falck-Ytter; Joerg Meerpohl; Craig Whittington; Kristian Thorlund; Jeff Andrews; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-08-11       Impact factor: 6.437

2.  GRADE guidelines: 9. Rating up the quality of evidence.

Authors:  Gordon H Guyatt; Andrew D Oxman; Shahnaz Sultan; Paul Glasziou; Elie A Akl; Pablo Alonso-Coello; David Atkins; Regina Kunz; Jan Brozek; Victor Montori; Roman Jaeschke; David Rind; Philipp Dahm; Joerg Meerpohl; Gunn Vist; Elise Berliner; Susan Norris; Yngve Falck-Ytter; M Hassan Murad; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-30       Impact factor: 6.437

3.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; James Woodcock; Jan Brozek; Mark Helfand; Pablo Alonso-Coello; Paul Glasziou; Roman Jaeschke; Elie A Akl; Susan Norris; Gunn Vist; Philipp Dahm; Vijay K Shukla; Julian Higgins; Yngve Falck-Ytter; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-31       Impact factor: 6.437

4.  Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.

Authors:  John H Beigel; Evgenia Aga; Marie-Carmelle Elie-Turenne; Josalyn Cho; Pablo Tebas; Carol L Clark; Jordan P Metcalf; Caroline Ozment; Kanakatte Raviprakash; Joy Beeler; H Preston Holley; Stephanie Warner; Carla Chorley; H Clifford Lane; Michael D Hughes; Richard T Davey
Journal:  Lancet Respir Med       Date:  2019-09-30       Impact factor: 30.700

5.  Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.

Authors:  John H Beigel; Pablo Tebas; Marie-Carmelle Elie-Turenne; Ednan Bajwa; Todd E Bell; Charles B Cairns; Shmuel Shoham; Jaime G Deville; Eric Feucht; Judith Feinberg; Thomas Luke; Kanakatte Raviprakash; Janine Danko; Dorothy O'Neil; Julia A Metcalf; Karen King; Timothy H Burgess; Evgenia Aga; H Clifford Lane; Michael D Hughes; Richard T Davey
Journal:  Lancet Respir Med       Date:  2017-05-15       Impact factor: 30.700

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.

Authors:  Eric H Y Lau; Benjamin J Cowling; Matthew P Muller; Lai-Ming Ho; Thomas Tsang; Su-Vui Lo; Marie Louie; Gabriel M Leung
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

8.  Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

Authors:  Y O Y Soo; Y Cheng; R Wong; D S Hui; C K Lee; K K S Tsang; M H L Ng; P Chan; G Cheng; J J Y Sung
Journal:  Clin Microbiol Infect       Date:  2004-07       Impact factor: 8.067

9.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

10.  Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.

Authors:  Hoe-Nam Leong; Brenda Ang; Arul Earnest; Cindy Teoh; Wei Xu; Yee-Sin Leo
Journal:  Trop Med Int Health       Date:  2004-08       Impact factor: 2.622

View more
  21 in total

1.  Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.

Authors:  Wei Liu; Pengxiang Zhou; Ken Chen; Zhikang Ye; Fang Liu; Xiaotong Li; Na He; Ziyang Wu; Qi Zhang; Xuepeng Gong; Qiyu Tang; Xin Du; Yingqiu Ying; Xiaohan Xu; Yahui Zhang; Jinyu Liu; Yun Li; Ning Shen; Rachel J Couban; Quazi I Ibrahim; Gordon Guyatt; Suodi Zhai
Journal:  CMAJ       Date:  2020-06-03       Impact factor: 8.262

2.  Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.

Authors:  Niveditha Devasenapathy; Zhikang Ye; Mark Loeb; Fang Fang; Borna Tadayon Najafabadi; Yingqi Xiao; Rachel Couban; Philippe Bégin; Gordon Guyatt
Journal:  CMAJ       Date:  2020-05-22       Impact factor: 8.262

3.  Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-05-14       Impact factor: 8.262

4. 

Authors:  Niveditha Devasenapathy; Zhikang Ye; Mark Loeb; Fang Fang; Borna Tadayon Najafabadi; Yingqi Xiao; Rachel Couban; Philippe Bégin; Gordon Guyatt
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

5. 

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

Review 6.  Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective.

Authors:  Saly Kanj; Basem Al-Omari
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

7.  First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.

Authors:  Magdalena Figlerowicz; Anna Mania; Karol Lubarski; Zuzanna Lewandowska; Wojciech Służewski; Katarzyna Derwich; Jacek Wachowiak; Katarzyna Mazur-Melewska
Journal:  Transfus Apher Sci       Date:  2020-07-01       Impact factor: 1.764

Review 8.  Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.

Authors:  Carolina Ferreira; Sofia D Viana; Flávio Reis
Journal:  Microorganisms       Date:  2020-10-01

9.  Quality of and Recommendations for Relevant Clinical Practice Guidelines for COVID-19 Management: A Systematic Review and Critical Appraisal.

Authors:  Yun-Yun Wang; Qiao Huang; Quan Shen; Hao Zi; Bing-Hui Li; Ming-Zhen Li; Shao-Hua He; Xian-Tao Zeng; Xiaomei Yao; Ying-Hui Jin
Journal:  Front Med (Lausanne)       Date:  2021-06-10

Review 10.  Pregnancy and COVID-19: pharmacologic considerations.

Authors:  R D'Souza; R Ashraf; H Rowe; J Zipursky; L Clarfield; C Maxwell; C Arzola; S Lapinsky; K Paquette; S Murthy; M P Cheng; I Malhamé
Journal:  Ultrasound Obstet Gynecol       Date:  2021-02       Impact factor: 8.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.